Heart Failure Treatment (Inpatient) vs PSA (Prostate-Specific Antigen)
Medicare Cost Comparison 2025
Quick Answer
Heart Failure Treatment (Inpatient): $18,000 total · Medicare pays $14,400 · Patient pays $3,600
PSA (Prostate-Specific Antigen): $40 total · Medicare pays $32 · Patient pays $8
Cost Comparison
| Metric | Heart Failure Treatment (Inpatient) | PSA (Prostate-Specific Antigen) |
|---|---|---|
| Total Average Cost | $18,000 | $40 |
| Medicare Pays | $14,400 | $32 |
| Patient Pays | $3,600 | $8 |
| Category | hospital | lab |
FAQ
What is the cost difference between Heart Failure Treatment (Inpatient) and PSA (Prostate-Specific Antigen)?
Heart Failure Treatment (Inpatient) costs $18,000 on average, while PSA (Prostate-Specific Antigen) costs $40 — a difference of $17,960.
How much does Medicare pay for Heart Failure Treatment (Inpatient) vs PSA (Prostate-Specific Antigen)?
Medicare typically pays $14,400 for Heart Failure Treatment (Inpatient) (patient owes $3,600). For PSA (Prostate-Specific Antigen), Medicare pays $32 (patient owes $8).
What is Heart Failure Treatment (Inpatient)?
Inpatient management of congestive heart failure symptoms.
What is PSA (Prostate-Specific Antigen)?
Blood test for prostate cancer screening.